|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2010-3-12
|
|
pubmed:abstractText |
The National Institute for Health and Clinical Excellence (NICE) was reviewing its previous guidance on continuous subcutaneous insulin infusion (CSII). The review provided an assessment of evidence which had been published since the previous NICE appraisal (TA 151) in 2007.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1366-5278
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
iii-iv, xi-xvi, 1-181
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:20223123-Adult,
pubmed-meshheading:20223123-Aged,
pubmed-meshheading:20223123-Child,
pubmed-meshheading:20223123-Child, Preschool,
pubmed-meshheading:20223123-Cost-Benefit Analysis,
pubmed-meshheading:20223123-Diabetes Mellitus, Type 2,
pubmed-meshheading:20223123-Female,
pubmed-meshheading:20223123-Great Britain,
pubmed-meshheading:20223123-Humans,
pubmed-meshheading:20223123-Infusions, Subcutaneous,
pubmed-meshheading:20223123-Insulin,
pubmed-meshheading:20223123-Male,
pubmed-meshheading:20223123-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.
|
|
pubmed:affiliation |
The Aberdeen HTA Group, University of Aberdeen, Aberdeen, UK.
|
|
pubmed:publicationType |
Journal Article,
Review
|
